Copyright
©The Author(s) 2004.
World J Gastroenterol. Feb 15, 2004; 10(4): 525-530
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.525
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.525
Variants | NO of cases 97 | VEGF expression | Significance | ||
- | + | ++ | |||
Pathological grade | |||||
Grade I | 6 | 6 | 0 | 0 | NS |
Grade II | 76 | 28 | 22 | 26 | |
Grade III-IV | 15 | 8 | 3 | 4 | |
Tumor size | |||||
2 | 13 | 11 | 0 | 2 | NS |
2-5 | 49 | 16 | 14 | 19 | |
> 5 | 35 | 15 | 11 | 9 | |
Cirrhosis | |||||
With | 53 | 20 | 10 | 23 | NS |
Without | 44 | 22 | 15 | 7 | |
Capsule formation | |||||
With | 18 | 7 | 5 | 6 | NS |
Without | 79 | 35 | 20 | 24 | |
Capsule infiltration | |||||
With | 16 | 4 | 2 | 10 | 0.011a |
Without | 81 | 38 | 23 | 20 | |
Portal vein infiltration | |||||
With | 48 | 14 | 16 | 18 | 0.020a |
Without | 49 | 20 | 9 | 12 | |
Necrosis | |||||
With | 54 | 15 | 17 | 22 | 0.011a |
Without | 43 | 27 | 8 | 8 |
- Citation: Bangoura G, Yang LY, Huang GW, Wang W. Expression of HIF-2α/EPAS1 in hepatocellular carcinoma. World J Gastroenterol 2004; 10(4): 525-530
- URL: https://www.wjgnet.com/1007-9327/full/v10/i4/525.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i4.525